Articles tagged with Tuberculosis
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A new TB drug candidate, PA-824, has been shown to be effective against MDR strains of the bacteria. The compound, developed by PathoGenesis Corporation with assistance from NIAID's Laboratory of Host Defenses, works by preventing MTB from forming an important fatty acid component of its cell walls.
Susan Okie, a medical reporter at The Washington Post, has won the 2000 American Society for Microbiology (ASM) Public Communications Award. Her two-part series on tuberculosis highlights the challenges of controlling this deadly disease and emphasizes the need for new medicines and vaccines to eradicate it.
Researchers have created a mutant strain of Mycobacterium tuberculosis that fails to establish a lethal chronic infection in mice. Targeting the pcaA gene, which codes for an enzyme essential for virulence, may lead to breakthroughs in TB treatment.
Researchers found that treated sleep apnea patients experienced no auto accidents over two years. A new biochemical marker for acute lung injury has been discovered, correlating with damage to epithelial cells in the lungs. This discovery may lead to future blood tests for the deadly condition.
A new rapid and reliable method for detecting tuberculosis has been developed, using the microscopic observation broth-drug susceptibility assay (MODS). The test is inexpensive and sensitive enough to be used in the field by health officers in developing countries.
The Tuberculosis Research Unit at CWRU will work with seven basic science sites and three clinical sites to evaluate new drugs, vaccines, and diagnostic tests. The unit aims to alleviate the burden of TB, which affects 1.7 billion people worldwide.
Researchers at Johns Hopkins Medicine reported a groundbreaking case of tuberculosis transmission from a cadaver to an embalmer, revealing the first documented instance of such a transmission. The study emphasizes the need for updated guidelines and precautions to prevent similar incidents in funeral homes.
Researchers from the Howard Hughes Medical Institute identified a crucial lipid molecule produced by M. tuberculosis to infect lung tissue. The discovery could lead to improved vaccines and treatments for tuberculosis, which kills more people than AIDS or malaria.
Two groups of researchers at Colorado State University will receive funding to develop new drugs against tuberculosis, a leading bacterial killer causing 10 million new cases annually. The research teams will collaborate with pharmaceutical companies and use advanced testing infrastructure to identify potential anti-TB compounds.
The report highlights the rapid spread of multidrug-resistant tuberculosis (MDR-TB) to Western Europe and North America, reaching unprecedented levels in over 100 countries. Immediate implementation of the World Health Organization's DOTS program and new resources are urgently needed to combat the growing epidemic.
A study found that TB was transmitted among inmates and guards in a city jail, highlighting the need for aggressive TB detection and treatment. Meanwhile, a qualitative study identified five components of successful work with victims of domestic violence and emphasized the importance of 'compassionate asking' to address this complex so...
Researchers at UCSF have discovered how Mycobacterium tuberculosis outsmarts the immune system to cause disease. The microbe disrupts a protein called STAT1, blocking macrophages' ability to respond to interferon gamma, allowing it to survive and infect other cells.
Researchers have identified 15 M. tuberculosis genes expressed only when the bacteria are growing in macrophages, key disease-fighting cells. These genes play important roles in pathogen metabolism, propagation and self-protection, potentially leading to new drug targets or vaccines.
Researchers have identified a substance produced by the tuberculosis bacterium that triggers an immune response, suggesting it could enhance vaccine effectiveness. The substance, combined with vaccines, may push the body's immune system in the right direction to fight tuberculosis and other microbial infections.
A new study by UCSF researchers found a significant decline in TB rates in San Francisco from 1992 to 1997, attributing it to intensified control measures. The study used molecular epidemiology to track the disease and determine the effect of interventions on transmission rates.
A new report by Johns Hopkins Medicine highlights the inadequate tuberculosis control programs in developing countries, particularly in sub-Saharan Africa where HIV infection rates are high. The report recommends improved screening, treatment, and integration of TB and HIV care to reduce transmission.
A new study suggests that crowded urban buses in Buenos Aires could be responsible for 30% of new tuberculosis cases. Researchers found that bus travel increases the risk of infection due to overcrowding and poor ventilation, posing a significant public health threat.
Researchers developed a code using first two letters of last name, first name, month of birth, year of birth, and sex. This allowed them to identify 124 HMO members with active TB listed in the state's registry but not known by their HMO
The development of a new vaccine is crucial to effectively eliminate tuberculosis (TB) as a global health problem. The ideal vaccine should prevent new infection, protect those already infected from developing active disease, and prevent reinfection in previously infected individuals.
Scientists have identified KasA, a critical protein in bacterial growth, as the target of isoniazid. This discovery enables the development of new anti-TB drugs and fast-screening assays to combat antibiotic-resistant strains.
Scientists have developed a new TB vaccine candidate that uses recombinant BCG strains to secrete pore-forming listeriolysin, improving its ability to stimulate CD8 T cells. This could lead to better protection against M. tuberculosis infection and potentially halve the estimated 2050 global TB cases.
A simplified regimen of twice-weekly isoniazid preventive therapy for six months or rifampicin and pyrazinamide for two months was found to be effective in preventing active tuberculosis in HIV-infected individuals. Higher compliance with treatment was observed among those who received the shorter course of treatment.
A two-month course of therapy is an effective alternative to the year-long regimen for preventing active tuberculosis in HIV-infected individuals. The study found that fewer deaths occurred among patients in the two-drug arm, with improved treatment compliance compared to the one-drug arm.
Researchers found that using rapid diagnostic methods for M. tuberculosis can decrease diagnosis time from 38.5 to 23 days, time to therapy from 6.6 to 2.0 days, and mortality by 22-33%. This also reduces healthcare costs per patient.
Researchers discovered identical DNA fingerprints in bacterial cultures from two TB patients who were bronchoscoped at the same hospital. The study emphasizes the importance of maintaining TB DNA fingerprint registries to identify unsuspected transmission modes.
Researchers have created an efficient method to study Mycobacterium tuberculosis (TB) using transposon mutagenesis, allowing them to examine the effect of individual gene mutations on the bacteria's ability to grow or cause disease. This breakthrough enables the development of new drug targets and potential vaccine candidates.
Tuberculosis bacteria use the C2a protein to lure macrophages to their death, a strategy that makes them effective pathogens. Understanding this mechanism may lead to the development of a novel vaccine to prevent tuberculosis.
Researchers found that HIV-positive patients living in the eastern United States are at a higher risk of developing tuberculosis, particularly if they have low levels of CD4 cells. The study also revealed that nearly 25% of those diagnosed with TB died from the disease.
Researchers at Johns Hopkins have found that spending more time and money on strict drug regimens saves money in the long run. The cost-effective strategy, called directly observed therapy (DOT), cures more people sooner and decreases the risk of developing TB germs resistant to treatment.